We have located links that may give you full text access.
Changes in ocular blood flow velocities during external counterpulsation in healthy volunteers and patients with atherosclerosis.
BACKGROUND: External counterpulsation (ECP) is a new noninvasive means of augmenting organ perfusion by applying ECG-triggered diastolic pressure to the vascular bed of the lower limbs. In this study, effects of ECP on changes of ocular blood flow velocities were studied.
METHOD: Mean, systolic and diastolic flow velocities of the ophthalmic artery were measured by Doppler sonography before and during ECP. Twelve healthy volunteers (age 31.3+/-4.3 years) and 12 patients with severe atherosclerosis (inclusion criteria: two atherosclerotic risk factors, at least one severe coronary stenosis, age 62.1+/-5.3 years) were included in the study.
RESULTS: In healthy subjects, ECP changed diastolic flow velocity of the ophthalmic artery nonsignificantly from 21.6+/-7.7 to 23.7+/-10.5 cm/s. Systolic flow velocity decreased significantly from 36.1+/-13.6 to 28.9+/-10.2 cm/s (P<0.01). Mean flow velocity changed nonsignificantly from 28.1+/-9.4 to 26.5+/-9.9 cm/s. In atherosclerotic patients, mean flow velocity increased significantly from 26.3+/-11.4 to 29.3+/-11.2 cm/s (P<0.001), which was caused by significant diastolic flow augmentation from 19.7+/-9.1 to 23.9+/-9.7 cm/s (P<0.001). Systolic flow velocity was not changed significantly (from 34.2+/-12.8 to 32.6+/-11.8 cm/s).
CONCLUSION: No significant change of mean blood flow velocity in the ophthalmic artery was found in young healthy subjects. In elderly patients with atherosclerosis, ECP significantly increased blood flow velocity in the ophthalmic artery by 11.4%. This may indicate an ocular perfusion benefit in these patients as a result of ECP and could also explain the increase of perfusion found in patients with retinal ischemia after ECP.
METHOD: Mean, systolic and diastolic flow velocities of the ophthalmic artery were measured by Doppler sonography before and during ECP. Twelve healthy volunteers (age 31.3+/-4.3 years) and 12 patients with severe atherosclerosis (inclusion criteria: two atherosclerotic risk factors, at least one severe coronary stenosis, age 62.1+/-5.3 years) were included in the study.
RESULTS: In healthy subjects, ECP changed diastolic flow velocity of the ophthalmic artery nonsignificantly from 21.6+/-7.7 to 23.7+/-10.5 cm/s. Systolic flow velocity decreased significantly from 36.1+/-13.6 to 28.9+/-10.2 cm/s (P<0.01). Mean flow velocity changed nonsignificantly from 28.1+/-9.4 to 26.5+/-9.9 cm/s. In atherosclerotic patients, mean flow velocity increased significantly from 26.3+/-11.4 to 29.3+/-11.2 cm/s (P<0.001), which was caused by significant diastolic flow augmentation from 19.7+/-9.1 to 23.9+/-9.7 cm/s (P<0.001). Systolic flow velocity was not changed significantly (from 34.2+/-12.8 to 32.6+/-11.8 cm/s).
CONCLUSION: No significant change of mean blood flow velocity in the ophthalmic artery was found in young healthy subjects. In elderly patients with atherosclerosis, ECP significantly increased blood flow velocity in the ophthalmic artery by 11.4%. This may indicate an ocular perfusion benefit in these patients as a result of ECP and could also explain the increase of perfusion found in patients with retinal ischemia after ECP.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app